Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Inventory (2012 - 2026)

Kamada's (KMDA) quarterly Inventory came in at $86.9 million in Q2 2026, up 5.84% on a YoY basis from $82.1 million in Q2 2025, and up 1.68% quarter-over-quarter from $85.4 million in Q1 2026.

Analysis

Kamada (KMDA) Inventory (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Inventory for 15 consecutive years, with $86.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Inventory rose 5.84% year-over-year to $86.9 million; the trailing twelve-month figure through Jun 2026 stood at $86.9 million (up 5.84% YoY), and the FY2025 full-year result was $84.9 million, up 7.77% from the prior year.
  • Inventory grew to $86.9 million in Q2 2026 per KMDA's latest filing, from $85.4 million in the prior quarter.
  • Across five years, Inventory topped out at $88.5 million in Q4 2023 and bottomed at $64.5 million in Q2 2022.
  • Historically, Inventory has averaged $78.3 million across 5 years, with a median of $79.3 million in 2023.
  • The sharpest annual moves came in 2022 and 2024: Inventory surged 57.36% in 2022, then slipped 10.92% in 2024.
  • Over 5 years, Inventory stood at $68.8 million in 2022, then increased by 28.63% to $88.5 million in 2023, then fell by 10.92% to $78.8 million in 2024, then increased by 7.77% to $84.9 million in 2025, then increased by 2.27% to $86.9 million in 2026.
  • According to Business Quant data, Inventory over the past three periods registered $86.9 million, $85.4 million, and $84.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Amgen 211.39 Bn 197.40 Bn 7.24 Bn 6.22 Bn
2 Gilead Sciences 181.14 Bn 177.96 Bn 6.22 Bn 1.95 Bn
3 Vertex Pharmaceuticals 132.24 Bn 124.39 Bn 2.84 Bn 1.77 Bn
4 Regeneron Pharmaceuticals 82.91 Bn 74.91 Bn 3.93 Bn 3.08 Bn
5 Argenx Se 61.55 Bn 56.36 Bn 1.37 Bn 371.00 Mn
6 Moderna 54.39 Bn 49.25 Bn 52.00 Mn 280.00 Mn
7 Alnylam Pharmaceuticals 34.43 Bn 31.12 Bn 992.69 Mn 97.11 Mn
8 Biogen 31.18 Bn 29.89 Bn 1.96 Bn 2.38 Bn
9 Roivant Sciences 30.11 Bn 30.11 Bn 1.16 Mn -
10 Kamada 472.70 Mn 402.57 Mn 22.47 Mn 86.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 86.88 Mn
Mar 31, 2026 85.44 Mn
Dec 31, 2025 84.94 Mn
Sep 30, 2025 85.41 Mn
Jun 30, 2025 82.08 Mn
Mar 31, 2025 78.36 Mn
Dec 31, 2024 78.82 Mn
Sep 30, 2024 71.56 Mn
Jun 30, 2024 78.71 Mn
Mar 31, 2024 84.35 Mn
Dec 31, 2023 88.48 Mn
Sep 30, 2023 73.80 Mn
Jun 30, 2023 80.24 Mn
Mar 31, 2023 79.75 Mn
Dec 31, 2022 68.79 Mn
Sep 30, 2022 73.03 Mn
Jun 30, 2022 64.52 Mn
Mar 31, 2022 64.76 Mn
Dec 31, 2021 67.42 Mn
Sep 30, 2021 48.16 Mn